Malignant Ampulla of Vater Neoplasm — Trials

Malignant Ampulla of Vater Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03139487	A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY)	unknown	Phase 2	176	Asan Medical CenterOTHER	1	Jan 6, 2020	clinicaltrials

Data updated 22 days agoSource updated Jan 6, 2020source: clinicaltrials